Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Northern Hemisphere 2009/2010 seasonal influenza vaccine immunogenicity and safety study in children 6 to 35 months
ISRCTN10483274Phase 3Completed
- Sponsor
- Berna Biotech AG
- Start
- Sep 2009
- Modality
- Vaccines & Immunotherapeutics, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Inflexal V and influenza vaccine in influenza (2 arms), sponsored by Berna Biotech AG. Primary endpoint: Immunogenicity. Started Sep 2009; status: completed.
02
Drugs
Inflexal Vinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ISRCTN10483274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10483274.